Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Analytical reliability and patient experience of a microblade-based self-collection device for reproductive hormone monitoring: a paired-sample pilot study.

Created on 29 Jul 2026

Authors

Pedro Royo, Alberto Pacheco, Fernando Quintana, Nacho Gómez-Trenor, Juan A García-Velasco

Published in

Reproductive biomedicine online. Volume 53. Issue 4. Pages 105843. Jul 28, 2026. Epub Jul 28, 2026.

Abstract

Can a microblade-based self-collection device (Tasso+, Tasso, USA) provide analytically reliable measurements of key reproductive hormones compared with standard venous sampling under controlled conditions, and does it improve patient experience during IVF monitoring?
A multicentre, pilot, paired-sample study was conducted in 39 women undergoing IVF treatment. Paired venous and Tasso+ samples were collected during the same clinical visit and anti-Mullerian hormone (AMH), oestradiol and progesterone concentrations were analysed at 0, 24, 48 and 72 h under controlled storage at 4°C. Agreement was assessed using Pearson correlation coefficients, intra-class correlation coefficients (ICC) and Bland-Altman analyses. Patient experience was evaluated using a structured questionnaire.
Hormone concentrations obtained via Tasso+ showed excellent agreement with venous sampling across all analytes and time points (Pearson's r = 0.948-0.998, ICC = 0.948-0.998). AMH and oestradiol remained stable for up to 72 h at 4°C, with minimal bias and narrow limits of agreement. Progesterone maintained high agreement at 24 h but showed increasing dispersion at 48 and 72 h. Patient-reported experience was favourable across all domains, with overall mean scores ranging from 7.80 to 8.18 on a 10-point Likert scale.
Under controlled clinical and laboratory conditions, Tasso+ provides analytically reliable measurements of AMH, oestradiol and progesterone with favourable patient acceptability. AMH and oestradiol concentrations remained stable for up to 72 h at 4°C, whereas progesterone samples should ideally be analysed within 24 h for clinical decision making. These findings support the further evaluation of self-collection devices as complementary tools in patient-centred IVF monitoring pathways.

PMID:
42520328
Bibliographic data and abstract were imported from PubMed on 29 Jul 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 5
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement